Back
EHRA Premium Access

Insights from the Castle AF: why was it positive?

Session: Atrial fibrillation (AF) in HFrEF, HFmrEF and HFpEF: does it make any difference?
Topic: Heart Failure in Atrial Fibrillation
Speaker: Professor N. Marrouche (New Orleans, US)
Event: EHRA 2022

Congress Presentation

About the speaker

Professor Nassir Marrouche

Tulane University, New Orleans (United States of America)
27 presentations
1 follower

4 more presentations in this session

AF in HFrEF, HFmrEF and HFpEF: does it make any difference?

Speaker: Professor R. De Boer (Rotterdam, NL)

Access
Slides
Video
Thumbnail

SGLT2 blockers in AF: the best AAD ever?

Speaker: Professor F. Ruschitzka (Zurich, CH)

Access
Slides
Video
Thumbnail

The future of AF ablation in heart failure.

Speaker: Professor D. Gupta (Liverpool, GB)

Access
Slides
Video
Thumbnail

Atrial Fibrillation (AF) in HFrEF, HFmrEF and HFpEF: does it make any difference? - discussion.

Access
Video
Thumbnail

Access the full session

Atrial fibrillation (AF) in HFrEF, HFmrEF and HFpEF: does it make any difference?

Speakers: Professor N. Marrouche, Professor R. De Boer, Professor F. Ruschitzka, Professor D. Gupta
Access
Video
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb